Freek Verheugt

Showing 1-7 of 7 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Bivalirudin in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: uncertainties almost clarified

Huber K, Verheugt F

March 20, 2017 | 10.4244/EIJV12I16A315

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial

Dewilde W, Janssen P, Kelder J, Verheugt F, de Smet B, Adrianssens T, Vrolix M, Brueren G, Vandendriessche T, Van Mieghem C, Cornelis K, Vos J, Breet N, ten Berg J

August 20, 2015 | 10.4244/EIJY14M06_07

A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients

Vranckx P, Verheugt F, de Maat MP, Ulmans V, Regar E, Smits P, ten Berg J, Lindeboom W, Jones R, Friedman J, Reilly P, Leebeek F

January 18, 2013 | 10.4244/EIJV8I9A162

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study

Hamon M, Rao S, Steg G, Valgimigli M, Verheugt F, Marso S, Gershlick A, Wang Y, Deliargyris E

August 24, 2012 | 10.4244/EIJV8I4A76

Triggering mechanisms of stent thrombosis

Zwart B, van Werkum J, Heestermans A, Kelder J, Zomer A, van’t Hof A, Verheugt F, ten Berg J

January 20, 2011

Effect of PCI on inflammatory markers, adiponectin and insulin resistance

Gomes M, Smits P, Verheugt F, Tack C

February 25, 2010

1

Latest news

PCR e-Course; LM interventions; FFR and STEMI, the EAPCI and COVID-19; TMVR

Ahead of print: EAPCI Core Curriculum for PCI (2020)

IVUS guidance during left main PCI: not if, but when and how

Ahead of print: EAPCI Expert Consensus Document: Ischaemia with non-obstructive coronary arteries

V. Kunadian et al

Left main PCI: are we giving the kiss the attention it deserves?

Find the latest trials:

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

This Week's JAA's: CULPRIT-SHOCK substudy, Coronary Microcatheter Complications...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke